Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibrx Biosciences

12.04
+0.31502.69%
Volume:25.44K
Turnover:300.28K
Market Cap:174.22M
PE:0.11
High:12.05
Open:11.59
Low:11.45
Close:11.72
Loading ...
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Sep 20, 2023

Major Issues Report

Form 8-K - Current report
Aug 29, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
May 30, 2023

Major Issues Report

Form 8-K - Current report
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2023

Major Issues Report

8-K - Current report
Apr 26, 2023

Major Issues Report

8-K - Current report
Mar 13, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 06, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 06, 2023

Major Issues Report

8-K - Current report
Mar 06, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals